Free Trial
→ Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (From Behind the Markets) (Ad) Buy ADAP Stock  Free ADAP Stock Alerts

Adaptimmune Therapeutics (ADAP) SEC Filings & 10K Form

Adaptimmune Therapeutics logo
$0.28 +0.01 (+5.17%)
As of 04:00 PM Eastern
Compare

Recent Adaptimmune Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/25/2025
7:02 AM		Adaptimmune Therapeutics (Filer)
Form DEF 14A
04/15/2025
7:00 AM		Adaptimmune Therapeutics (Filer)
Form PRE 14A
04/14/2025
3:10 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:40 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:44 PM		Adaptimmune Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
6:09 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
4:34 PM		Adaptimmune Therapeutics (Issuer)
Brewer Joanna Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:35 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:31 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:32 PM		Adaptimmune Therapeutics (Issuer)
Piccina Cintia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:33 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:31 AM		Adaptimmune Therapeutics (Subject)
Two Seas Capital LP (Filed by)
Form SCHEDULE 13G
02/12/2025
9:25 AM		Adaptimmune Therapeutics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SCHEDULE 13G/A
01/17/2025
8:15 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:16 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:17 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:17 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
2:07 PM		Adaptimmune Therapeutics (Subject)
Norry Elliot (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:42 PM		Adaptimmune Therapeutics (Subject)
Rawcliffe Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:50 PM		Adaptimmune Therapeutics (Subject)
Bertrand William C JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:59 PM		Adaptimmune Therapeutics (Subject)
Lunger John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:15 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:16 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:17 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:18 PM		Adaptimmune Therapeutics (Issuer)
Piccina Cintia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:19 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
2:43 PM		Adaptimmune Therapeutics (Subject)
Lunger John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
2:50 PM		Adaptimmune Therapeutics (Subject)
Norry Elliot (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
2:34 PM		Adaptimmune Therapeutics (Subject)
Rawcliffe Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
9:30 AM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SCHEDULE 13G/A
12/19/2024
6:40 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:17 PM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SCHEDULE 13G/A
11/13/2024
8:04 AM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/13/2024
8:10 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:00 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:23 AM		Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:05 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
6:00 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:30 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/15/2024
6:39 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:14 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:34 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ADAP) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners
Top performing AI play of the decade…? (The answer will shock you)
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
M.A.G.A. is Finished – This Could be even Better
You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...
Paradigm Press | Sponsored
China’s next move could destroy U.S. tech
The U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...
Investors Alley | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored